Association of Monocyte-to-HDL Cholesterol Ratio with Endothelial Dysfunction in Patients with Type 2 Diabetes
Table 3
Association of MHR levels with endothelial dysfunction.
Model 1
Model 2
Model 3
Crude OR (95% CI)
value
OR (95% CI)
value
OR (95% CI)
value
MHR per 0.1
1.35 (1.08-1.70)
0.010
1.34 (1.04-1.73)
0.026
1.35 (1.02-1.77)
0.033
MHR tertiles
Tertile 1
1 (REF)
—
1 (REF)
—
1 (REF)
—
Tertile 2
1.29 (0.64-2.62)
0.47
1.07 (0.50-2.27)
0.86
0.94 (0.42-2.12)
0.89
Tertile 3
3.62 (1.51-8.68)
0.004
3.70 (1.40-9.85)
0.009
3.50 (1.24-9.93)
0.020
trend
1.80 (1.20-2.70)
0.004
1.76 (1.13-2.75)
0.013
1.70 (1.06-2.73)
0.027
MHR per SD
1.61 (1.12-2.30)
0.010
1.59 (1.06-2.38)
0.026
1.60 (1.04-2.46)
0.033
Model 1: unadjusted; model 2: adjusted for sex, age, BMI, disease course, hypertension, smoking, and drinking; model 3: further adjusted for HbA1c, HOMA-IR, C-reactive protein, and TG in addition to confounders in model 2; OR: odds ratio; 95% CI: 95 % confidence interval.
